Final Business and Regulatory Impact Assessment: Human Tissue (Authorisation) (Scotland) Bill. Retrieved from <a href="https://beta.gov.scot/publications/human-tissue-authorisation-scotland-bill-business-regulatory-impact-assessment/" target="_blank">https://beta.gov.scot/publications/human-tissue-authorisation-scotland-bill-business-regulatory-impact-assessment/</a> provides the following summary of the potential costs and benefits of the policy based on the 3 estimates of effect:
Table 7 - Summary costs and benefits table for the introduction of a soft opt-out system (including theatre productivity)Total benefit years 1-5: economic, environmental, socialTotal cost years 1-5: economic, environmental, social, policy and administrative1 - Baseline estimate£0.00m£5.27m2 - Best estimate£48.62m£13.74m3 - High estimate£102.46m£22.54m